A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Clinical trial NCT00426764 · COMPLETED

Trial details

NCT number: NCT00426764
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2007-06-19
Primary completion: 2010-11-11
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.